NEW YORK (GenomeWeb News) – DermTech today announced that it has raised $5.6 million in a private round of financing to support future development and commercialization of its qPCR-based melanoma detection assay.

Jacobs Investment Company led the Series B financing with additional investments coming from other existing and new investors, which were not named.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Researchers report that paternally inherited genes are more likely to be expressed in mice.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.